← Back to patent-cliff list
CAS 17199-29-0
(S)-2-hydroxy-2-phenylacetic acid
Codes: GLYC-009, ROTI-005
Application context (from source-drug indications)
AsthmaBudesonide/Formoterol fumarate/Glycopyrronium BromideChronic obstructive pulmonary diseaseBudesonide/Formoterol fumarate/Glycopyrronium BromideChronic obstructive pulmonary diseaseIndacaterol Maleate/Glycopyrronium BromideRestless legs syndromeRotigotineParkinson's diseaseRotigotineSubstance-related disorderRotigotineDrug-related adverse effects and reactionsRotigotineTissue adhesionsRotigotinePostoperative painRotigotineSialorrhoeaGlycopyrronium BromideChronic obstructive pulmonary diseaseGlycopyrronium BromideDuodenal ulcerGlycopyrronium BromideGastric ulcerGlycopyrronium BromideGastritisGlycopyrronium BromideAnaesthesiaGlycopyrronium Bromide
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Budesonide/Formoterol fumarate/Glycopyrronium Bromide | Tier B — Position early | - |
| Indacaterol Maleate/Glycopyrronium Bromide | Tier B — Position early | - |
| Rotigotine | Tier C — Watch / trade | - |
| Glycopyrronium Bromide | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
bromocyclopentane→(S)-2-hydroxy-2-phenylacetic acid→(2S,5S)-2-(tert-butyl)-5-phenyl-1,3-dioxolan-4-one→(2S,5S)-2-(tert-butyl)-5-cyclopentyl-5-phenyl-1,3-dioxolan-4-one→(S)-2-cyclopentyl-2-hydroxy-2-phenylacetic acid→methyl (S)-2-cyclopentyl-2-hydroxy-2-phenylacetate→(R)-1-methylpyrrolidin-3-ol→(R)-1-methylpyrrolidin-3-yl (S)-2-cyclopentyl-2-hydroxy-2-phenylacetate
bromocyclopentane→(S)-2-hydroxy-2-phenylacetic acid→(2S,5S)-2-(tert-butyl)-5-phenyl-1,3-dioxolan-4-one→(2S,5S)-2-(tert-butyl)-5-cyclopentyl-5-phenyl-1,3-dioxolan-4-one→(S)-2-cyclopentyl-2-hydroxy-2-phenylacetic acid→methyl (S)-2-cyclopentyl-2-hydroxy-2-phenylacetate→(R)-1-methylpyrrolidin-3-ol→(R)-1-methylpyrrolidin-3-yl (S)-2-cyclopentyl-2-hydroxy-2-phenylacetate
naphthalene-1,6-diol→1,6-dimethoxynaphthalene→5-methoxy-3,4-dihydronaphthalen-2(1H)-one→5-methoxy-1,2,3,4-tetrahydronaphthalen-2-amine→(S)-2-hydroxy-2-phenylacetic acid→(S)-5-methoxy-1,2,3,4-tetrahydronaphthalen-2-amine (S)-2-hydroxy-2-phenylacetate→(S)-5-methoxy-1,2,3,4-tetrahydronaphthalen-2-amine→2-(thiophen-2-yl)ethyl 4-methylbenzenesulfonate→(S)-5-methoxy-N-(2-(thiophen-2-yl)ethyl)-1,2,3,4-tetrahydronaphthalen-2-amine hydrochloride→propionic acid→(S)-5-methoxy-N-propyl-N-(2-(thiophen-2-yl)ethyl)-1,2,3,4-tetrahydronaphthalen-2-amine hydrochloride
bromocyclopentane→(S)-2-hydroxy-2-phenylacetic acid→(2S,5S)-2-(tert-butyl)-5-phenyl-1,3-dioxolan-4-one→(2S,5S)-2-(tert-butyl)-5-cyclopentyl-5-phenyl-1,3-dioxolan-4-one→(S)-2-cyclopentyl-2-hydroxy-2-phenylacetic acid→methyl (S)-2-cyclopentyl-2-hydroxy-2-phenylacetate→(R)-1-methylpyrrolidin-3-ol→(R)-1-methylpyrrolidin-3-yl (S)-2-cyclopentyl-2-hydroxy-2-phenylacetate
Intermediates available on this site
Side-by-side comparison of all listed offers on this CAS; price bands are list-price ranges, final price subject to RFQ confirmation.
| Supplier | Product | Price band | MOQ | Lead time | Qualifications | Action |
|---|---|---|---|---|---|---|
| Qualified Partner — East China API Works | 5-Methoxy-2-tetralone Pharmaceutical Intermediates | On request | On request | On request | — | |
| Unibest Nantong cGMP Site | (S)-2-AMINO-5-METHOXYTETRALIN HYDROCHLORIDE Pharmaceutical Intermediates | On request | On request | On request | — | |
| Unibest Taizhou GMP-like Site | (S)-2-Amino-5-methoxytetralin Hydrochloride Pharmaceutical Intermediates | On request | On request | On request | — | |
| Qualified Partner — East China API Works | (S)-1,2,3,4-Tetrahydro-5-methoxy-N-propyl-2-naphthalenamine hydrochloride Pharmaceutical Intermediates | On request | On request | On request | — | |
| Unibest Nantong cGMP Site | (S)-2-Amino-5-methoxytetralin (S)-mandelate Pharmaceutical Intermediates | On request | On request | On request | — |
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.